Adv Ther Kanwar MK, Sunku R, Alruwaili F, Mufti MA, Raji M (2022) Beneficial effects of Glucagon-Like Peptide-1 receptor agonists in patients with asthma: a literature review
The Eating Disorder Risk Signal: What Every Prescriber Needs to Know As of 2026, GLP-1 medications carry no eating disorder warning on their FDA-approved labeling
I hope you found this helpful, and feel free to reach back out with any other questions
Published: Jun 2, 2026 Written by Klarity Editorial Team Published: Jun 2, 2026 If youre a psychiatrist or psychiatric nurse practitioner, youve probably noticed: your patients arent just asking about depression or ADHD anymore
After Novo Nordisks blockbuster weight loss drug Wegovy made its debut in Asia by launching in Japan last month, the pharma company says it now expects the drug to be approved in China this year
G.MarzlufG